Abstract:Lipoprotein(a) [Lp(a)] is a risk factor for cardiovascular events. This study evaluated the relationship between Lp(a) and high-risk attributes by coronary computed tomography angiography as well as their prognostic value. Lp(a) and coronary computed tomography angiography from 377 consecutive patients at Zhongshan Hospital (Shanghai, China) were evaluated. High-risk attributes were defined as high-risk morphological attributes (low attenuation plaque, positive remodeling, napkin-ring sign, spotty calcification, minimum lumen area <4 mm 2 , or plaque burden [ratio between cross-sectional plaque area at the site of maximum stenosis and cross-sectional vessel area] ≥70%); inflammatory attribute represented by fat attenuation index; high-risk physiological attributes [lesion-specific ischemia defined by fractional flow reserve by coronary computed tomography angiography ≤0.8, physiologic diffuseness defined by fractional flow reserve by coronary computed tomography angiography pullback pressure gradient]. Total plaque volume in mm 3 was also quantified. Quintiles or binary classification of Lp(a) levels were used to evaluate its relationships with plaque features and clinical outcomes with ANOVA, Cox models, and log-rank tests, as appropriate. The major adverse cardiovascular event included cardiovascular death, nonfatal myocardial infarction, and target vessel revascularization. Lp(a) was significantly associated with total plaque volume ( P =0.004), fat attenuation index ( P =0.031), and fractional flow reserve by coronary computed tomography angiography pullback pressure gradient ( P =0.038). Patients with a high Lp(a) level had a higher total plaque volume (393.3 mm 3 versus 293.9 mm 3 , P <0.001), lower pullback pressure gradient (0.62 versus 0.69, P =0.023), higher fat attenuation index (−70.5HU versus −73.9HU, P =0.004), and higher incidence of major adverse cardiovascular event (14.5% versus 6.3%, adjusted hazard ratio: 2.52, 95% CI: 1.12–5.63, P =0.025). In a 4-group classification according to Lp(a) and high-risk attributes, patients with high Lp(a) and ≥3 high-risk attributes had the highest risk of major adverse cardiovascular event (25.9%; overall P <0.001). Causal mediation analysis revealed that around 40% of the prognostic effect of Lp(a) was mediated by high-risk attributes. Lp(a) level is associated with coronary computed tomography angiography high-risk characteristics, including morphologic, physiologic, and inflammatory attributes as well as major adverse cardiovascular event. This effect is partly mediated by inflammation and vulnerable plaque. URL: https://www.clinicaltrials.gov; Unique identifier: NCT05323227 Download figure Download PowerPoint

Lipoprotein (a) Interactions with Cholesterol-Containing Lipids on Angiographic Coronary Collateralization in Type 2 Diabetic Patients with Chronic Total Occlusion

Diabetic dyslipidemia impairs coronary collateral formation: An update

Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion

Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.

Correlation Between Lipoprotein(a) Concentration and Severity of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus

Combination of High-Density Lipoprotein Cholesterol and Lipoprotein(a) As a Predictor of Collateral Circulation in Patients with Severe Unilateral Internal Carotid Artery Stenosis or Occlusion

Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes

Reiation between serum giycated aibumin ievei and coronary coiiaterais in type 2 diabetic patients

Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome

Association Of Blood Pressure And Coronary Collateralization In Type 2 Diabetic And Nondiabetic Patients With Stable Angina And Chronic Total Occlusion

Impact of Coronary Collateralization on Long-Term Clinical Outcomes in Type 2 Diabetic Patients after Successful Recanalization of Chronic Total Occlusion

Reduced Coronary Collateralization in Type 2 Diabetic Patients with Chronic Total Occlusion

Relationship between serum lipoprotein (a) level and risk and severity of coronary atherosclerotic heart disease in patients with type 2 diabetes mellitus

Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.

Association of Lipoprotein (a) With Coronary-Computed Tomography Angiography–Assessed High-Risk Coronary Disease Attributes and Cardiovascular Outcomes

Clinical and Angiographic Features Associated with Coronary Collateralization in Stable Angina Patients with Chronic Total Occlusion

HDL-C/apoA-I Ratio is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome.

Lipoprotein(A) Complexes With Beta2-Glycoprotein I In Patients With Coronary Artery Disease

Association of Lipoprotein Subfractions With Presence and Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography

Correlation of Lipoprotein (a) with Clinical Stability and Severity of Coronary Artery Lesions in Patients with Coronary Artery Disease

Association between lipoprotein(a) and cardiovascular disease in patients undergoing coronary angiography